Litigation

Recent Posts

Abbott, B. Braun, Boehringer Ingelheim Settle Drug-Pricing Cases For $421M
Posted on 8 Dec 2010 by Tom Moylan

BOSTON -- (Mealey's) Drug and medical supply makers Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories (now known as Boehringer Ingelheim Roxane Inc.) have agreed to pay a total of $421 million to settle False Claims Act allegations... Read More

Another Specialty Pharmacy Settles Exjade False Claims Allegations For $45 Million
Posted on 1 May 2015 by Tom Moylan

NEW YORK —(Mealey’s) Specialty pharmacy Accredo Health Group Inc. on April 30 agreed to pay $45 million to settle a whistle-blower’s allegations that its efforts to push prescriptions for the iron chelation drug Exjade resulted in false... Read More

2nd Circuit Sends N.J. Whistle-Blower Claims Of Ex-Pfizer Executive Back For Reconsideration
Posted on 18 Nov 2010 by Tom Moylan

NEW YORK -- (Mealey's) A Second Circuit U.S. Court of Appeals panel on Nov. 17 affirmed summary judgment on federal False Claims Act (FCA) termination claims by former Pfizer executive Peter Rost but reversed judgment as to his claims under New Jersey's... Read More

Medtronic Escapes Fraud Claims In Off-Label Stent Litigation
Posted on 28 Jul 2011 by Tom Moylan

BOSTON - (Mealey's) Finding that two whistle-blowers' False Claims Act (FCA) allegations failed to meet federal pleading requirements for fraud, a Massachusetts federal judge on July 27 dismissed claims that Medtronic Inc. promoted biliary stents... Read More